Is This "Little Pink Pill" the Viagra for Women?

Cue Card preview image

General Information

NBC Nightly News
Lester Holt/Kate Snow
Event Date:
Air/Publish Date:
Resource Type:
Video News Report
NBCUniversal Media, LLC.
Copyright Date:
Clip Length:


An outside panel will evaluate a new drug called Flibanserin seeking FDA approval that could potentially change the sex lives for millions of women.



"Is This "Little Pink Pill" the Viagra for Women?" Kate Snow, correspondent. NBC Nightly News. NBCUniversal Media. 2 June 2015. NBC Learn. Web. 3 May 2017.


Snow, K. (Reporter), & Holt, L. (Anchor). (2015, June 2). Is This "Little Pink Pill" the Viagra for Women? [Television series episode]. NBC Nightly News. Retrieved from


"Is This "Little Pink Pill" the Viagra for Women?" NBC Nightly News, New York, NY: NBC Universal, 06/02/2015. Accessed Wed May 3 2017 from NBC Learn:


Is This "Little Pink Pill" the Viagra for Women?

LESTER HOLT, anchor:

We're back now with a story that will be of high interest to a lot of adults. It's definitely an adult topic, about a little pink pill now under consideration by the FDA. There's no shortage of sex pills being marketed for men. Many of them you see during commercial breaks on this broadcast, but why not for women? And is that all about to change? Our national correspondent Kate Snow reports.

KATE SNOW, reporting:

Amanda and Ben Parrish were crazy about each other when they met after their first marriages broke up, but a few years in, things changed.

AMANDA PARRISH: I was becoming one of those people who would try to be in bed and maybe pretend to be asleep before Ben came to bed.

SNOW: But then Amanda signed up for a clinical trial for a little pink pill she took every night.

A. PARRISH: It didn't make me feel any differently during the day. What it did do was at the end of a long day, no matter how tired I was, I wanted to initiate and it was not work to do that. Things were different.

SNOW: Amanda was testing a drug intended for premenopausal women diagnosed with what doctors call distressing low sexual desire. In that trial funded by the drug maker, women on the drug flibanserin reported "improvements in sexual desire" and one more "satisfying sexual event" per month than women not taking the drug.

DR. KENNETH PAUL ROSENBERG (Weill Cornell Medical College): This drug alters the chemical make-up of the brain. It increases dopamine and that enables the brain to feel more sexual, to have more desire, more arousal.

WOMAN (advertisement): It's just you and your lady.

SNOW: Part of the PR blitz for the drug, a snide parody of all those commercials aimed at men.

WOMAN (advertisement): Are we really so far behind that we don't think women have the right to sexual desire.

DR. ADRIANE FUGH-BERMAN (Georgetown University Medical Center): For the FDA to approve the drug would be giving in to a public relations campaign.

SNOW: Twice before, the FDA refused to approve flibanserin, asking for more data on safety concerns like whether the side effect of sleepiness would impair driving. Other concerns? Today the FDA mentioned low blood pressure, fainting spells and whether those issues get worse if women drink alcohol while taking the pill. The drug maker tells NBC News patients will be advised to avoid alcohol use until they know how flibanserin affects them. What about people who think this might just be a pharmaceutical company looking to make another buck?

BEN PARRISH: We know that it works? I mean we experienced it.

SNOW: There's no perfect drug, the Parrish say, but this one sure has their friends talking. Kate Snow, NBC News, Nashville.